Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CENTERSPACE Director's Dealing 2023

Jan 4, 2023

32208_dirs_2023-01-04_97d47fcf-b2b3-40e5-9e55-bffb7e50b2ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CENTERSPACE (CSR)
CIK: 0000798359
Period of Report: 2023-01-01

Reporting Person: Olson Anne (COO, Gen Counsel and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-01-01 Common Shares of Beneficial Interest M 540 Acquired 14633 Direct
2023-01-01 Common Shares of Beneficial Interest M 373 Acquired 15006 Direct
2023-01-01 Common Shares of Beneficial Interest F 450 $58.67 Disposed 14556 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-01-01 Restricted Stock Units $0.0 A 3022 Acquired Common Shares of Beneficial Interest (3022.0) Direct
2023-01-01 Stock Options (Right to Buy) $58.67 A 11294 Acquired 2033-01-01 Common Shares of Beneficial Interest (11294.0) Direct
2023-01-01 Restricted Stock Units $0.0 M 540 Disposed 2024-01-01 Common Shares of Beneficial Interest (540.0) Direct
2023-01-01 Restricted Stock Units $0.0 M 373 Disposed 2025-01-01 Common Shares of Beneficial Interest (373.0) Direct

Footnotes

F1: Shares withheld for payment of taxes in connection with the vesting of restricted stock units.

F2: Represents a time-based contingent right to receive 3,022 common shares of beneficial interest of Centerspace vesting over three years in one-third increments on each anniversary of the grant date: January 1, 2024, 2025 and 2026.

F3: Represents the right to purchase 11,294 common shares of beneficial interest of Centerspace, vesting over four years in one-fourth increments on each anniversary of the grant date: January 1, 2024, 2025, 2026 and 2027.